These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15596777)

  • 21. Treatment of multifocal motor neuropathy with interferon-beta1A.
    Van den Berg-Vos RM; Van den Berg LH; Franssen H; Van Doorn PA; Merkies IS; Wokke JH
    Neurology; 2000 Apr; 54(7):1518-21. PubMed ID: 10751269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intravenous immunoglobulin in multifocal motor neuropathy.
    Leger JM; Vargas S; Lievens I
    Ann N Y Acad Sci; 2007 Sep; 1110():248-55. PubMed ID: 17911439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab therapy in monoclonal IgM-related neuropathies.
    Kilidireas C; Anagnostopoulos A; Karandreas N; Mouselimi L; Dimopoulos MA
    Leuk Lymphoma; 2006 May; 47(5):859-64. PubMed ID: 16753870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How long is IVIg effective in multifocal motor neuropathy?
    Terenghi F; Cappellari A; Bersano A; Carpo M; Barbieri S; Nobile-Orazio E
    Neurology; 2004 Feb; 62(4):666-8. PubMed ID: 14981195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
    Lehmann HC; Hartung HP
    J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives].
    Léger JM; Chassande B
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.
    Hahn AF; Beydoun SR; Lawson V; ; Oh M; Empson VG; Leibl H; Ngo LY; Gelmont D; Koski CL
    J Peripher Nerv Syst; 2013 Dec; 18(4):321-30. PubMed ID: 24725024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy.
    Leger JM; Younes-Chennoufi AB; Chassande B; Davila G; Bouche P; Baumann N; Brunet P
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):46-9. PubMed ID: 7964853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substantial Improvement in a Nerve Conduction Study of Lymphoma-associated Demyelinating Neuropathy Treated by Intravenous Immunoglobulin and Chemotherapy.
    Iemura T; Oba A; Matsui M; Mano C; Kawabata N; Horisawa Y; Miyahara Y; Itoh M
    Intern Med; 2018 Dec; 57(23):3467-3472. PubMed ID: 30101902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
    Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
    Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma.
    Vincent-Salomon A; Mathiot C; Macintyre E; Girre V; Fourquet A; Mercier C; Fréneaux P; Dumont J; Decaudin D
    Leuk Lymphoma; 2000 Apr; 37(3-4):387-91. PubMed ID: 10752990
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of IgM antibody associated polyneuropathies using rituximab.
    Pestronk A; Florence J; Miller T; Choksi R; Al-Lozi MT; Levine TD
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):485-9. PubMed ID: 12640069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody.
    Rech J; Hueber AJ; Kallert S; Leipe J; Kalden JR; Beck M; Schett G; Schulze-Koops H
    Ther Apher Dial; 2008 Jun; 12(3):205-8. PubMed ID: 18503697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon beta-1a as adjunctive treatment for multifocal motor neuropathy: an open label trial.
    Radziwill AJ; Botez SA; Novy J; Kuntzer T
    J Peripher Nerv Syst; 2009 Sep; 14(3):201-2. PubMed ID: 19909484
    [No Abstract]   [Full Text] [Related]  

  • 35. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.
    Davis TA; Grillo-López AJ; White CA; McLaughlin P; Czuczman MS; Link BK; Maloney DG; Weaver RL; Rosenberg J; Levy R
    J Clin Oncol; 2000 Sep; 18(17):3135-43. PubMed ID: 10963642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies.
    Comi G; Nemni R; Amadio S; Galardi G; Leocani L
    Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg.
    Vucic S; Black KR; Chong PS; Cros D
    Neurology; 2004 Oct; 63(7):1264-9. PubMed ID: 15477549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):38-42. PubMed ID: 7964851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biological treatment of multiple sclerosis].
    Sørensen PS; Sellebjerg F
    Ugeskr Laeger; 2008 Jun; 170(24):2156-9. PubMed ID: 18565303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.